- Home
- IMRX vs PYXS Comparison
IMRX vs PYXS Comparison
Compare IMRX & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- PYXS
- Stock Information
- Founded
- IMRX 2008
- PYXS 2018
- Country
- IMRX United States
- PYXS United States
- Employees
- IMRX N/A
- PYXS N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- IMRX Health Care
- PYXS Health Care
- Exchange
- IMRX Nasdaq
- PYXS Nasdaq
- Market Cap
- IMRX 232.9M
- PYXS 243.5M
- IPO Year
- IMRX 2021
- PYXS 2021
- Fundamental
- Price
- IMRX $7.49
- PYXS $5.19
- Analyst Decision
- IMRX Strong Buy
- PYXS Strong Buy
- Analyst Count
- IMRX 5
- PYXS 4
- Target Price
- IMRX $17.20
- PYXS $7.00
- AVG Volume (30 Days)
- IMRX 1.2M
- PYXS 742.8K
- Earning Date
- IMRX 11-12-2025
- PYXS 11-03-2025
- Dividend Yield
- IMRX N/A
- PYXS N/A
- EPS Growth
- IMRX N/A
- PYXS N/A
- EPS
- IMRX N/A
- PYXS N/A
- Revenue
- IMRX N/A
- PYXS $2,820,000.00
- Revenue This Year
- IMRX N/A
- PYXS N/A
- Revenue Next Year
- IMRX N/A
- PYXS N/A
- P/E Ratio
- IMRX N/A
- PYXS N/A
- Revenue Growth
- IMRX N/A
- PYXS N/A
- 52 Week Low
- IMRX $1.10
- PYXS $0.83
- 52 Week High
- IMRX $10.08
- PYXS $5.24
- Technical
- Relative Strength Index (RSI)
- IMRX 62.47
- PYXS 72.27
- Support Level
- IMRX $6.62
- PYXS $4.47
- Resistance Level
- IMRX $7.50
- PYXS $5.11
- Average True Range (ATR)
- IMRX 0.62
- PYXS 0.39
- MACD
- IMRX 0.08
- PYXS 0.03
- Stochastic Oscillator
- IMRX 91.19
- PYXS 96.06
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.